Recent studies have shown that PCK1 functions as a regulator of hepatic energy metabolism and gluconeogenesis, with its dysregulation linked to metabolic diseases, such as diabetes, obesity, insulin resistance, and tumor development [23–25]. Here, PCK1 is linked to Other metabolic disease.